Mutational analysis of the insulinlike growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients

By              

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1073-1079

Science Publishers

Access to resources Recommend Favorite

In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer

By            

Oncology Reports, Vol. 31, Iss. 1, 2014-01 ,pp. : 87-94

Spandidos Publications

Access to resources Recommend Favorite

Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 5, 2011-06 ,pp. : 427-433

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes

By Goodwin P.J.  

Breast Cancer Research and Treatment, Vol. 74, Iss. 1, 2002-07 ,pp. : 65-76

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of the Insulin-Like Growth Factor-1 Receptor Enhances Effects of Simvastatin on Prostate Cancer Cells in Co-Culture with Bone

By Nordstrand Annika   Lundholm Marie   Larsson Andreas   Lerner Ulf   Widmark Anders   Wikström Pernilla  

Cancer Microenvironment, Vol. 6, Iss. 3, 2013-12 ,pp. : 231-240

Springer Publishing Company

Access to resources Recommend Favorite